Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Econazole Nitrate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : DPT Laboratories, Ltd
Deal Size : Inapplicable
Deal Type : Inapplicable
Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea Pedis
Details : Econazole nitrate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Tinea Pedis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 26, 2017
Lead Product(s) : Econazole Nitrate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : DPT Laboratories, Ltd
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Econazole Nitrate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Cross Research S.A.
Deal Size : Inapplicable
Deal Type : Inapplicable
Tolerability and Pharmacokinetic Study of Econazole Nitrate Plus Benzydamine HCl Vaginal Pessary
Details : Econazole nitrate is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 28, 2016
Lead Product(s) : Econazole Nitrate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Cross Research S.A.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Econazole Nitrate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Cross Research S.A.
Deal Size : Inapplicable
Deal Type : Inapplicable
Tolerability and Pharmacokinetic Study of Econazole Nitrate and Benzydamine HCl Intravaginal Cream
Details : Econazole nitrate is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 21, 2016
Lead Product(s) : Econazole Nitrate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Cross Research S.A.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Econazole Nitrate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : AmDerma Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Econazole nitrate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Tinea Pedis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 01, 2012
Lead Product(s) : Econazole Nitrate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : AmDerma Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Econazole Nitrate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : AmDerma Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Tinea Pedis
Details : Econazole nitrate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Tinea Pedis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 23, 2011
Lead Product(s) : Econazole Nitrate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : AmDerma Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Econazole Nitrate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : AmDerma Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis
Details : Econazole nitrate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Tinea Pedis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 16, 2011
Lead Product(s) : Econazole Nitrate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : AmDerma Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable